abstract |
Administration of the known drug 5-o-cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-c] pyridine methanesulfonate ("MS salt" or "PCR") is described for the alleviation of the symptoms of senility such as of organic brain syndrome and senile dementia. |